or
forgot password
  • cancer clinical trials in pittsburgh, PA

  • Bevacizumab, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Stage II or Stage III Multiple Myeloma
    University of Pittsburgh Cancer Institute
    Pittsburgh, Pennsylvania 15213
    Refractory Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
    Western Pennsylvania Hospital
    Pittsburgh, Pennsylvania 15224
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma
    University of Pittsburgh Medical Center Department of Dermatology
    Pittsburgh, Pennsylvania 15213
    Cutaneous T-Cell Lymphoma
    AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
    UPMC Cancer Centers
    Pittsburgh, Pennsylvania 15232
    Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Allegheny Cancer Center at Allegheny General Hospital

    Trial Locations
    Allegheny Cancer Center at Allegheny General Hospital
    University of Pittsburgh
    Magee-Womens Hospital - University of Pittsburgh Medical Center
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
    Allegheny Cancer Center at Allegheny General Hospital

    Trial Locations
    Allegheny Cancer Center at Allegheny General Hospital
    Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
    Lung Cancer
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Trial of Dasatinib in Advanced Sarcomas
    University of Pittsburgh Cancer Institute
    Pittsburgh, Pennsylvania 15213
    Rhabdomyosarcoma, Malignant Peripheral Nerve Sheath Tumors, Chondrosarcoma, Sarcoma, Ewing's, Sarcoma, Alveolar Soft Part, Chordoma, Epithelioid Sarcoma, Giant Cell Tumor of Bone, Hemangiopericytoma, Gastrointestinal Stromal Tumor (GIST)
    Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer
    University of Pittsburgh

    Trial Locations
    University of Pittsburgh
    NSABP Foundation, Inc.
    Allegheny General Hospital/Allegheny-Singer Research Institute
    Breast Cancer
    Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
    The Western Pennsylvania Hospital

    Trial Locations
    The Western Pennsylvania Hospital
    University of Pittsburgh Cancer Institute/UPMC Cancer Centers
    Hematologic Malignancies, Acute Myeloid Leukemia, Lymphoid Leukemia, Chronic Myeloid Leukemia, Hodgkin's Disease, Non-Hodgkin's Lymphoma, Myelodysplastic Syndromes
    Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy
    University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania 15213
    Bone Loss, Osteoporosis, Breast Cancer
    A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer
    Western Pennsylvania Hospital

    Trial Locations
    Western Pennsylvania Hospital
    University of Pittsburgh
    NSABP Foundation, Inc.
    Allegheny General Hospital/Allegheny-Singer Research Institute
    Invasive Breast Cancer
    Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    Allegheny Cancer Center at Allegheny General Hospital
    Pittsburgh, Pennsylvania 15212
    Lung Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Allegheny Cancer Center at Allegheny General Hospital
    Pittsburgh, Pennsylvania 15212
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Neuroblastoma
    Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction
    University of Pittsburgh
    Pittsburgh, Pennsylvania 15261
    Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
    Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors
    University of Pittsburgh Medical Center Hillman Cancer Center
    Pittsburgh, Pennsylvania
    Advanced Neuroendocrine Tumors
    IGIV Study for Chronic ITP Patients Ages 3-70
    Western Pennsylvannia Hospital
    Pittsburgh, Pennsylvania 15224
    Idiopathic Thrombocytopenic Purpura
    Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
    University of Pittsburgh Cancer Institute
    Pittsburgh, Pennsylvania 15213
    Gastroesophageal Junction Adenocarcinoma, Gastric Cancer
    Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital
    Pittsburgh, Pennsylvania 15224-1791
    Lymphoma
    Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
    UPMC Cancer Centers
    Pittsburgh, Pennsylvania 15232
    Multiple Myeloma and Plasma Cell Neoplasm
    Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.
    GSK Investigational Site
    Pittsburgh, Pennsylvania 15213
    Neoplasms, Breast
    Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
    University of Pittsburgh Cancer Institute

    Trial Locations
    University of Pittsburgh Cancer Institute
    University of Pittsburgh
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2), Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Leukemia
    Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer
    University of Pittsburgh Medical Centers
    Pittsburgh, Pennsylvania 15213
    Pancreatic Cancer
    Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases
    UPMC Cancer Centers Network
    Pittsburgh, Pennsylvania 15232
    Colorectal Liver Metastases
    Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer
    University of Cancer Institute
    Pittsburgh, Pennsylvania 15232
    Metastatic Colorectal Cancer
    Efficacy Study of ABR-215050 to Treat Prostate Cancer
    University of Pittsburgh Physicians, Department of Urology
    Pittsburgh, Pennsylvania 15232
    Prostate Cancer
    Sunitinib in Treating Patients With Recurrent or Unresectable Meningioma, Intracranial Hemangiopericytoma, or Intracranial Hemangioblastoma
    UPMC Cancer Centers
    Pittsburgh, Pennsylvania 15232
    Brain and Central Nervous System Tumors, Neurofibromatosis Type 1, Neurofibromatosis Type 2, Precancerous Condition
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    UPMC Cancer Center at Magee-Womens Hospital

    Trial Locations
    UPMC Cancer Center at Magee-Womens Hospital
    UPMC - Shadyside
    UPMC Cancer Center at UPMC St. Margaret
    UPMC Cancer Center at UPMC Passavant
    UPMC Cancer Center - Upper St. Clair
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
    Allegheny Cancer Center at Allegheny General Hospital

    Trial Locations
    Allegheny Cancer Center at Allegheny General Hospital
    UPMC Cancer Center at UPMC Presbyterian
    UPMC - Shadyside
    UPMC Cancer Center at UPMC St. Margaret
    UPMC Cancer Center at UPMC Passavant
    UPMC Cancer Center - Upper St. Clair
    Prostate Cancer
    Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck
    UPMC Cancer Center - Mercy

    Trial Locations
    UPMC Cancer Center - Mercy
    UPMC Cancer Center -Drake
    UPMC Cancer Center -Delafield Rd.
    University of Pittsburgh Cancer Institute-Hillman Cancer Center
    Adenoid Cystic Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    VA Pittsburgh Healthcare System
    Pittsburgh, Pennsylvania 15240
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary